NCT03035058.
Trial name or title | NCT03035058. |
Methods | Randomised, double‐blind, placebo‐controlled trial. |
Participants | Patients with primary sclerosing cholangitis. |
Interventions | Vedolizumab vs placebo. |
Outcomes | No outcomes of interest for this review. |
Starting date | February 2017. |
Contact information | medicalinformation@tpna.com |
Notes |
vs = versus